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Sec14Sec14 family homologs are the major yeast phosphatidylinositol/phosphatidylcholine transfer pro-
teins regulating lipid metabolism and vesicle trafﬁcking. The structure of Saccharomyces cerevisiae
Sfh3 displays a conserved Sec14 scaffold and reveals determinants for the speciﬁc recognition of
phosphatidylinositol ligand. Apo-Sfh3 forms a dimer through the hydrophobic interaction of gating
helices. Binding of phosphatidylinositol leads to dissociation of the dimer into monomers in a
reversible manner. This study suggests that the substrate induced dimer–monomer transformation
is an essential part of lipid transfer cycles by Sfh3.
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The biogenesis of organelle membranes requires the coordi-
nated transport of proteins and speciﬁc lipids from sites of synthe-
sis to sites where they are required. Lipids are moved between
cellular compartments by vesicular transport and non-vesicular
pathways involving lipid transfer proteins (LTPs). Phosphoinosi-
tides (PIs), phosphorylated derivatives of phosphatidylinositol
(PtdIns), are important components of membrane-associated sig-
naling systems in eukaryotes where they serve as second messen-
gers and signal integrators [1]. The major phosphoinositide species
are concentrated at distinct sites in intracellular membrane traf-
ﬁcking pathways and serve as organelle markers [2]. PtdIns is syn-
thesized in the ER and is subsequently transported to the plasma
membrane where it is converted to PIs by phosphatidylinositol ki-
nases [3].
Sec14 of Saccharomyces cerevisiae was originally identiﬁed as a
phosphatidylinositol transfer protein (PITP) that catalyzes the
in vitro transport of PtdIns and phosphatidylcholine (PtdCho) be-
tween artiﬁcial and biological membranes [4]. The protein appears
to be multifunctional, with cellular functions ranging from inter-
membrane phospholipid transport to substrate presentation tolipid-modifying enzymes. In addition, Sec14 plays an essential role
in protein transport from the trans-Golgi complex to the cell
periphery [5]. The yeast genome encodes ﬁve genes named
SFH1–5 (SEC 14 homologues) whose products exhibit signiﬁcant
sequence homolog to Sec14 [6]. Sfh1 displays the highest sequence
identity (64%) to Sec14. Sfh2–5 represent novel PITPs that exhibit
PtdIns – but not PtdCho-transfer activity in vitro [7]. Over-expres-
sion of Sfh2, Sfh4, and Sfh5 leads to suppression of sec14-related
growth and secretion defects. Deletion of SFH3 and SFH4 results
in sensitivity to several antifungal drugs [8]. Deletion of SFH3 has
a pronounced effect on the sterol composition of plasma mem-
brane, and SFH4 deletion results in alteration of the phospholipid
patterns of plasma membrane in yeast [8]. Structural studies of
Sfh1 have revealed that it binds the PtdCho and PtdIns headgroups
at physically distinct sites [9]. PtdCho-binding and PtdIns-binding
are both required for the biological function of Sec14. It was pro-
posed that Sec14 performs heterotypic exchange of PtdCho for
PtdIns with regulated conformational transitions [9,10]. These
ﬁndings led to a model in which Sec14/Sfh1 functions as a nanore-
actor for PtdCho-regulated presentation of PtdIns to PtdIns kinases,
thereby affecting PI synthesis and regulating speciﬁc membrane-
trafﬁcking pathways [3,11].
Sfh3 is distantly related to Sec14 and Sfh1, sharing 14% and 18%
primary sequence identities (31% and 33% similarity) respectively.
Sfh3 localizes to lipid particles and microsomes and catalyzes
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dues lining the ligand-binding pocket of Sfh3 compared to Sec14
suggests that it might have a different ligand speciﬁcity and a dis-
tinct lipid transfer mechanism from Sec14. In addition, the func-
tional properties of Sfh3 are fundamentally different from those
of Sec14 and Sfh1 [4,10].
To investigate Sfh3 function and ligand speciﬁcities from a
structural perspective, we have determined the structures of full-
length Sfh3 in the apo form and in complex with phosphatidylino-
sitol. The apo structure reveals a dimeric Sfh3 that is unique to the
Sec14 family homologs. Structural and biochemical studies indi-
cate that Sfh3 binds PtdIns, but does not bind PtdCho. PtdIns-bind-
ing changes the dimer–monomer equilibrium of Sfh3, which we
propose is an essential part of the lipid transfer cycle. From this
study, we have derived a model for the phosphatidylinositol trans-
fer cycle.
2. Materials and methods
The expression, puriﬁcation, crystallization of Sfh3, X-ray data
collection, structure determination and reﬁnement are described
in Supplementary material. The ﬁnal reﬁnement statistics are
shown in Table 1.
2.1. SEC analysis of Sfh3
DOPC (1,2-dioleoyl-sn-glycero-3-phosphocholine), POPS (1-pal-
mitoyl-2-oleoyl-sn-glycero-3-phospho-l-serine), were obtained
from Avanti Polar Lipids and PtdIns (L-a-phosphatidylinositol from
soybean) were obtained from Sigma–Aldrich. For the phospholipid
binding assay of Sfh3, each lipid in chloroform was dried under
nitrogen stream in glass tubes. Lipid ﬁlms were resuspended in
50 mM HEPES, pH 7.2, and 120 mM potassium acetate (HK buffer)
to a ﬁnal lipid concentration of 2 mM and sonicated for 3 min. Lip-
osomes were mixed with puriﬁed Sfh3 in a 10:1 molar ratio and
incubated at room temperature for 24 h. The mixture of Sfh3 and
the lipids was analyzed by size exclusion chromatography. The
monomeric form of PtdIns loaded Sfh3 was isolated from SEC frac-
tions and used for protein crystallization and lipid transfer assays.
For the SEC analysis of Sfh3–PtdIns samples incubated with lip-
osomes, DOPC and PtdIns in chloroform were mixed at a desiredTable 1
Statistics of data collection and crystallographic reﬁnement.
Crystal apo Sfh3
Se-Met
apo Sf
Native
Construct Residues 15–345
V100M
Residu
Wavelength (Å) 0.97941 (peak) 0.9794
X-ray source 7A, PLS 5C, PL
Space group P21 P21212
Unit cell a = 52.7 Å, b = 143.6 Å, c = 55.8 Å
b = 111.0
a = 53
Resolution (Å) (last shell) 1.9 (2.34–2.30) 2.0 (2.
No. of unique reﬂections 32983 59649
Redundancy 3.3 (3.0) 5.1 (5.
I/s(I)r (last shell) 23.2 (3.5) 30.2 (4
Rsym (%) 6.7 (30.8) 7.8 (41
Data completeness (%) 99.4 (98.7) 99.5 (9
Phasing Se-SAD MR
Overall FOM (50–2.3 Å) 0.44 (SOLVE) 0.65 (RESOLVE)
Reﬁnement
Rwork/Rfree 21.3/23.5 (24.5/29.3) 23.6/2
R.m.s. bond length (Å) 0.005 0.006
R.m.s. bong angle () 1.2 1.2
Average B value (Å2) 19.6 33.4
Number of atoms 5431(protein 5274, water 157) 5583 (
The values in parentheses relate to highest resolution shells.molar ratio, incubated at 37 C for 5 min and the solvent evapo-
rated under nitrogen. Dried lipids were resuspended in 1 ml of
HK buffer by vortexing. The hydrated lipid mixture was frozen
and thawed ﬁve times using a water bath and cooled ethanol at
70 C. The lipid mixture was extruded 10 times through a
0.1 lm polycarbonate ﬁlter. The ﬁnal lipid concentration of lipo-
somes was 2 mM. The liposomes and PtdIns–Sfh3 were mixed at
a desired molar ratio. After incubation at room temperature, sam-
ples were centrifuged at 14000 g for 10 min and the supernatants
were analyzed by SEC.3. Results
3.1. Overall structure of Sfh3
The structure of apo Sfh3 from S. cerevisiae was determined at
2.0 Å resolution by single anomalous dispersion (SAD) using sele-
nomethionine-labeled Sfh3 (Table 1). The structure consists of 11
a helices and 9 b-strands (Fig. 1A). The structure of Sfh3 consists
of two domains held together by an N-terminal extended loop (res-
idues 16–41) and a 34 Å-long C-terminal a helix (a10) (Fig. 1B).
The N-terminal domain consists of ﬁve a helices (a1, a2, a3, a4
and a11) and two short b strands. The C-terminal domain consists
of helices a5a9 and seven b-strands (b1, b4b8, and b9) and it
contains a large hydrophobic pocket with a surface area of
1500 Å2. The core of the C-terminal domain consists of a central
ﬁve-stranded b sheet (b4–b8) sandwiched between three a helices
and the C-terminal loop regions. The ﬁve b-strands constitute the
hydrophobic pocket ﬂoor. The a6 and a7 helices form one side of
the hydrophobic cavity, while a8 and a9 form the other side. The
seven residues in the b7–a7 loop were disordered and not visible
in the electron density maps. The interface between the N-terminal
and C-terminal domains creates a cavity composed mainly of
hydrophilic residues from a2–a4 of the N-terminal domain and
a6–a7 and the a7–b7 loop of the C-terminal domain. The hydro-
philic cavity has a volume of 600 Å3 and contains 25 ordered water
molecules. The a8 and a9 helices, known as gating helices of the
hydrophobic pocket, are open in the Sfh3 structure (Fig. 1C). The
helix a8 is involved in dimerization by making hydrophobic inter-
actions with helix a7 of the other protomer.h3
form
Sfh3–PtdIns complex
es 2–350 Residues 15–345
9 0.97949
S 5C, PLS
1 P21
.0 Å, b = 113.3 Å, c = 144.1 Å a = 52.9 Å, b = 144.1 Å, c = 55.7 Å
b = 111.3
03–2.00) 1.55 (1.58–1.55)
111015
1) 2.8 (2.7)
.1) 32.4 (4.3)
.2) 4.6 (35.0)
9.1) 99.1 (98.8)
MR
6.1 (26.1/30.7) 22.1/23.9 (24.8/27.1)
0.005
1.3
21.8
protein 5313, water 270) 5736 (protein 5358, water 319, PtdIns 59)
Fig. 1. Overall structure of Sfh3. (A) Sequence alignment of yeast Sec14 family homologs. The conserved hydrophilic residues recognizing the inositol head group of PtdIns are
indicated with red circles. The variable residues involved in PtdCho binding in Sec14 and Sfh1 homologs are indicated in green dots. The secondary structure elements of
gating helices a8 and a9 were colored red. (B) Cartoon representation of apo Sfh3 structure (C) Ribbon representation of PtdIns-bound Sfh3 monomer. Secondary structure
elements are colored to match those of (A).
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Size exclusion chromatography (SEC) analysis demonstrated
that the recombinant Sfh3 is a homogeneous dimer without a
detectable monomeric species, suggesting that dimeric Sfh3 is
a biologically relevant form (Fig. 2A). Dimeric Sfh3 was also re-
ported in a previous puriﬁcation and crystallization study [13].
Sfh3 crystallized as a dimer in the asymmetric unit with molec-
ular dimensions of 94  60  55 Å. The protomers in the dimer
are related by a non-crystallographic twofold axis (Fig. 2B). The
dimer interface is formed by association of two hydrophobic
binding pockets from each protomers. The gating helices a8
and a9 in an open conformation compose the center of the two-
fold axis in the dimer. Dimerization buries total 2048 Å2 of sur-
face area in two protomers. The dimer is stabilized by two
hydrogen bonds in the a8–a9 loop and hydrophobic interactions
between the a7 and a8 helices (Fig. 2C). The eight hydrophobic
residues in helix a8 make hydrophobic interaction with helix a7
of the other protomer. Helix a8 from the other protomer occu-pies a position close to where a8 is expected to be positioned
in the closed conformation of Sfh3, resulting in formation of
empty cavities in the ligand binding pockets of each protomer
in the dimer. However, the ligand binding pockets are partially
accessible for ligand binding from the solvent in the dimeric
state. Dissociation of the dimer into monomers seems to be
essential for the binding of PtdIns ligand. To prove this hypoth-
esis, oligomeric states of Sfh3 proteins incubated with various
phospholipids including PtdIns, PtdCho and PtdSer were ana-
lyzed by SEC. The apo Sfh3 is a dimer. We did not observe a
monomeric species during the puriﬁcation steps that are free
of PtdIns. Incubation of Sfh3 with PtdIns at a 1:10 molar ratio
dissociated the dimer into an exclusively monomeric form indi-
cating that Sfh3 is loaded with PtdIns ligand (Fig. 2A). Binding
of the ligand to Sfh3 would induce a closure of the gating helices
which inhibits dimerization by deforming the structure of dimer
interface. In contrast, incubation with PtdCho or PtdSer had no
effect on the oligomeric states of Sfh3 implying that Sfh3 selec-
tively binds to PtdIns.
Fig. 2. Dimeric structure of apo Sfh3. (A) SEC proﬁles of Sfh3 samples incubated with various phospholipids. (B) Overall structure of dimeric Sfh3. (C) Dimer interface of Sfh3.
Fig. 3. PtdIns binding site of Sfh3. (A) 2Fo-Fc electron density map on bound PtdIns in Sfh3 contoured at 0.8r. (B) Binding site of PtdIns head group. (C) Overview of PtdIns
binding in the hydrophobic pocket of Sfh3. (D) Structural comparison of PtdIns-bound Sfh1 and Sfh3. (E) Superposition of the ligand binding sites of Sfh1–PtdCho and Sfh3–
PtdIns complexes. The labels in parenthesis correspond to Sfh1.
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To elucidate the structural determinants of PtdIns binding, Sfh3
was loaded with soybean PtdIns, crystallized, and the structure
determined to 1.55 Å resolution by molecular replacement using
apo-Sfh3 (Table 1). The PtdIns molecule is well ordered in the
structure with strong electron density for the head group of the li-
gand and traceable density for the two acyl chains (Fig. 3A). The
PtdIns was modeled as the 18:0/18:1 molecular species. The PtdIns
is incorporated into the Sfh3 binding cavity in an orientation such
that the inositol headgroup is coordinated near the protein surface
and the acyl chains in the hydrophobic pocket. The phospho-inosi-
tol moiety of bound PtdIns forms extensive contacts with residues
from a2, a3, and a9 helices, and the a7–b7 and a8–b9 loops. The
Sfh3–PtdIns interactions involve seven hydrogen bonds with the
PtdIns headgroup (Fig. 3B). The headgroup phosphate is coordi-
nated by the main-chain amide nitrogens of Glu235, Arg236,
Leu237 and by the side chain of Lys241. The 2-hydroxyl group of
the inositol ring makes a hydrogen bond with the side chain of
Glu235, and the 4-hydroxyl group interacts with Arg107 (a4). In
addition, the 6-hydroxyl group makes a water-mediated contact
to the N-terminal end of helix a7. The two acyl chains of PtdIns
make extensive hydrophobic interaction with hydrophobic resi-
dues on the bottom and the wall of the binding pocket in a non-
speciﬁc manner, as suggested by weak and ill-deﬁned electron
density maps in these regions (Fig. 3C).
Structural comparison of Sfh3 with Sec14 and Sfh1 reveals the
determinants for ligand speciﬁcities. The sequences and theFig. 4. Oligomeric states of Shf3. (A) Dimeric structure of PtdIns bound Sfh3. (B) Surface
and PtdIns bound dimers. (D) Size exclusion chromatography proﬁles of PtdIns–Sfh3 inc
2 mM of liposomes at a 1:50 molar ratio resulting in 0.03 mM of a ﬁnal protein concentr
liposomes at a 1:50 molar ratio and incubated for 14 h prior to SEC analysis.geometries of the residues involved in the recognition of the phos-
phoinositol head group are well conserved in Sec14 superfamily
proteins indicating that PtdIns is a common ligand (Fig. 3D). In
addition, the sequence and shape of the gating helices are similar
in Sfh1 and Sfh3, though Sfh3 has an open conformation of gating
helices. In Sfh3, the N-terminal upstream region of helix a7 is dis-
ordered while this region forms an a-helix in Sfh1. The major func-
tional difference of Sfh3 from Sfh1 and Sec14 is the lack of PtdCho
binding activity. Sfh1 binds both PtdIns and PtdCho in overlapping
binding sites for two acyl chains but the head groups of each li-
gands are recognized by distinct sites in the hydrophobic pocket.
The head group of PtdCho is recognized by a cluster of hydrophilic
residues in the ﬂoor of the hydrophobic pocket formed by the b-
sheet of the C-terminal domain in Sfh1. The Structure of Sfh3 ex-
plains why it is incapable of binding PtdCho. The six hydrophilic
residues that recognize the head group of PtdCho in Sfh1 are all
hydrophobic residues in Sfh3 (Fig. 3E). The hydrophobic character
in the pocket ﬂoor excludes binding of any polar groups such as the
choline moiety of PtdCho.
3.4. Structural comparison of apo Sfh3 and Sfh3–PtdIns complex
Superposition of apo-Sfh3 and PtdIns-loaded Sfh3 indicates al-
most identical conformations of monomers (Ca rmsd = 0.28 Å).
The structural differences between the apo-form and the ligand
complex are the presence of PtdIns in the binding site and the
slight conformational adjustments of side chains of the ligand
binding residues. Unexpectedly, even though the monomericrepresentation of PtdIns bound Sfh3 dimer. (C) Structural comparison of apo dimer
ubated with various liposomes. The 1 mg of PtdIns-loaded Sfh3 was mixed with the
ation. For the sample corresponding to redline, 3 mg of PtdIns–Sfh3 was mixed with
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ture of Sfh3–PdIns complex showed an almost identical dimer ob-
served in the apo Sfh3 with Ca rmsd of 0.67 Å for dimers (Fig. 4A–
C). SEC analysis of the crystallized drop solution containing PtdIns–
Sfh3 crystals indicates a mixture of monomeric and dimeric spe-
cies, while the drop solutions lacking crystals have only mono-
meric species (data not shown). It is likely that the dimeric
conﬁguration of PtdIns–Sfh3 was induced by lattice formation dur-
ing the crystallization process. The ligand-bound monomer in a
closed formwould undergo a conformational change of gating heli-
ces to the open form for dimerzation. Despite the dimeric structure
of PtdIns-bound Sfh3 could be a crystallographic artifact, the struc-
ture of each protomer in the dimer with the open conformation
might represent the structure of a transient membrane bound form
during lipid transfer.
3.5. Dimer–monomer transition of Sfh3 is regulated by substrate
binding
To examine whether the PtdIns-induced change of oligomeric
states of Sfh3 is reversible, we analyzed the oligomeric state of
Sfh3 after incubating the PtdIns-loaded Sfh3 with several lipo-
somes of different lipid compositions (Fig. 4D). We hypothesized
that the transfer of bound PtdIns to liposomes would generate
unliganded Sfh3 that would spontaneously re-dimerize. The
PtdIns-loaded Sfh3 used in the experiment was exclusively mono-
meric (blue line). When PtdIns–Sfh3 was mixed with pure DOPC
liposomes at a 1:50 molar ratio and incubated for an hour, a very
small faction of dimeric Sfh3 was formed (green line). We assumed
that the equilibrium is leaned toward PdtIns extraction rather than
PdtIns transfer to DOPC liposomes due to the high afﬁnity of Sfh3
to PtdIns. In order to observe the dimer peak more clearly, we in-
creased the amount of protein and liposomes by using triple sam-
ple volumes and incubated for 14 h (red line). In this setup, the
formation of Sfh3 dimer was clearly visible. A large fraction of
Sfh3 was observed at the end of the void volume in SEC, indicating
liposome bound Sfh3. Still, the signiﬁcant fraction of Sfh3 re-
mained as a monomer probably due to the non-ideal condition ofFig. 5. Schematic models of lipid transfer cycles by Sfh3 and Sfh1. The lipid transfer cycl
Sfh1 was based on the previous studies [3,9]. The other protein components such lipidliposomes for lipid transfer compared to the physiological mem-
branes containing various lipids and other protein components.
The oligomeric state other than dimer or monomer was not ob-
served suggesting that the formation of Sfh3 dimer is a speciﬁc
outcome of ligand transfer. We exclude the possibility of artifactual
dimer formation simply by a high protein concentration in this
experiment, because PtdIns–Sfh3 at 15 mg/ml stays as homoge-
neous monomers when liposomes are absent. In contrast, when
DOPC liposomes were doped with 10% PtdIns, no dimeric Sfh3 ap-
peared due to the suppression of the ligand transfer by the pres-
ence of PtdIns in the acceptor membrane. This experiment
suggests that the dimer–monomer transition is regulated by PtdIns
binding in a reversible manner.
4. Discussion
Sec14 of S. cerevisiae catalyzes transport of PtdIns and PtdCho
between lipid membranes. Sec14 family homologs are proposed
to have two major conformations that are the ‘open’ form and
the ‘closed’ form. The ‘closed’ form with a bound lipid represents
the protein structure in solution [3,14]. The primary difference be-
tween the ‘open’ and ‘closed’ conformers is the repositioning of a
helical gate by up to 18 Å so that it closes the lipid binding pocket.
The open form approximates the conformer(s) involved in lipid ex-
change on membrane surfaces since it exposes the hydrophobic
pocket suitable for membrane binding and lipid extraction. The
open form of unliganded PITP is unlikely present in solution since
it exposes the extensive hydrophobic surface to the solvent. Con-
sistently, the structure of the open form of a PITP has only been ob-
served in complex with detergents bound to the hydrophobic
binding pocket of Sec14 [15]. The ligand binding pockets of
Sec14 proteins including Sfh1 seems to be always occupied by
PtdIns or PtdCho during the heterotypic ligand transfer cycles ex-
cept for the transient membrane bound state for lipid exchange
[9]. For Sec14 and Sfh1, the transport of PtdIns from the donor
membrane to the acceptor membranes requires delivery of PtdCho
back to the donor membrane to complete a heterotypic lipid trans-
fer cycle (Fig. 5). All PITPs characterized to date are monomers as ae of Sfh3 was proposed based on this study. The heterotypic lipid transfer model of
modifying enzymes on the membranes were omitted in these models.
1616 H. Yang et al. / FEBS Letters 587 (2013) 1610–1616physiologically active form [11]. In contrast, apo Sfh3 has an open
conformation of the gating helices which is distinct from Sec14
homologs. Dimerization of Sfh3 seems to allow this exception by
partially shielding the hydrophobic ligand binding pocket from
the solvent. In addition, dimerization of unliganded Sfh1 explains
the homotypic ligand transfer model that does not require binding
of the secondary phopholipid for reverse transport. This is consis-
tent with the lack of a PtdCho binding site in Sfh3. Based on these
results we propose a model for homotypic lipid transfer cycles of
Sfh3 (Fig. 5). Sfh3 performs a unidirectional transport of PtdIns to
acceptor membranes. Instead of counter-transporting PtdCho to
complete the cycle, Sfh3 recycles as unliganded dimers to the do-
nor membranes.
In summary, this study reveals that the ligand binding proper-
ties and molecular mechanisms of Shf3 are different from Sec14/
Sfh1. The structure of Sfh3 at 1.55 Å provides accurate details of
the PtdIns recognition in the ligand binding pocket. The results de-
scribed here provide clear validation for the homotypic lipid trans-
fer mode of Sfh3. How the distinct ligand speciﬁcity of Sfh3
translates into its biological function, however, still remains to be
elucidated.5. PDB accession number
Coordinates and structure factors for apo Sfh3 and Sfh3–PtdIns
complex have been deposited at the Protein Data Bank with acces-
sion codes 4J7P and 4J7Q, respectively.Acknowledgements
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